ACTRN12612000703808已完成未知
A cross-sectional cohort to assess the age-related changes to the function and morphology of the meibomian glands and the association of these changes to symptomatology in healthy people aged between 25 and less than 65 years of age
Brien Holden Vision Institute0 个研究点目标入组 200 人开始时间: 2012年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 25 Years 至 64 Years（—）
- 性别
- All
入选标准
- •Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent
- •Be aged between 25 and less than 65 years old, male or female
- •Have ocular health findings considered to be normal”
排除标准
- •Any pre-existing ocular irritation, injury or condition (including infection or disease) of the cornea, conjunctiva or eyelids (excluding dry eye).
- •Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, androgen deficiency and auto immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome, acne rosacea and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
- •Concurrent punctal occlusion
- •Use of or a need for concurrent category S4 and above ocular medication at enrolment and/or during the clinical trial.
- •Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology either in an adverse or beneficial manner at enrolment and/or during the clinical trial e.g. hormone replacement therapy or anti-androgen therapy.
- •NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used.
- •Eye surgery within 12 weeks immediately prior to enrolment for this trial.
- •Previous corneal refractive surgery.
- •Known allergy or intolerance to ingredients in any of the diagnostic products used during the clinical trial.
- •Currently enrolled in another clinical trial.
- •Participation in a clinical trial within the previous 2 weeks for dispensing studies and 48 hours between in-house studies.
- •Pregnancy: Formal testing of pregnancy is not required. A participant’s verbal report is sufficient.
- •The Investigator may, at his / her discretion, exclude anyone who they believe may not be able to fulfil the clinical trial requirements or it is believed to be in the participant’s best interests.
研究者
相似试验
进行中（未招募）
不适用
Can early introduction of dietary allergen reduce the prevalence of infant food allergy? The EarlyNuts population-based studyACTRN12618001990213Murdoch Children's Research Institute1,930
已完成
不适用
survey of tooth wear among wide-age ranged adultstooth wearJPRN-UMIN000041982Tokyo Medical and Dental University1,108
招募中
Unknown
Analysis of the method to choose regimens to treat pediatric heart failure in an age-dependent mannerPediatric heart failureJPRN-UMIN000052277Shinshu University25
撤回
不适用
Cross-sectional characterisation of elderly using the NeuroCart.10029299Alzheimer's diseasedementiaNL-OMON43551Centre for Human Drug Research1,000
已完成
不适用
Cross-sectional and cohort study investigating the diagnostic and prognositic function of Kampo (Japanese traditional medicine) findingspeople aged 65 or overJPRN-UMIN000003525Oriental Medicine Research Center, Kitasato University567